Skip to content

PRomoting Older Adults' Pneumococcal Vaccination Through Education and Learning

Assessing Barriers to Pneumococcal Vaccination to Increase Vaccine Uptake Among Older Adults: a Web-based Educational Intervention

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06234683
Acronym
PROPEL
Enrollment
720
Registered
2024-01-31
Start date
2024-03-06
Completion date
2024-12-12
Last updated
2025-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pneumococcal Vaccine Attitude, Pneumococcal Vaccine Knowledge, Pneumococcal Vaccine Uptake, Vaccination Willingness

Keywords

pneumococcal vaccines, older adults, vaccine hesitancy, health education, web-based intervention

Brief summary

The goal of this trial is to compare the effect of a web-based educational video about pneumococcal vaccines and a reminder email to get vaccinated (intervention) with a reminder email alone (comparator) in adults aged 65 or older living in any Canadian province who reported not having received a pneumococcal vaccine. The main questions this trial aims to answer are: 1. does the educational intervention improve pneumococcal vaccine uptake, 2. does the educational intervention improve willingness to be vaccinated, 3. does the educational intervention improve knowledge of pneumococcal vaccination, 4. and does the educational intervention improve attitudes towards pneumococcal vaccines/vaccination? Eligible participants who provide electronic consent will: 1. fill out a web-based baseline survey, 2. receive access to the educational video (if assigned to the intervention group), 3. receive an email reminder to be vaccinated (both groups), 4. and fill in a web-based follow-up survey.

Detailed description

This research project is a web-based randomized controlled trial (RCT), targeting adults aged 65 years and older across all Canadian provinces. The primary objectives of this study are twofold. Firstly, it aims to assess the participants' knowledge, barriers, facilitators, and willingness to receive the pneumococcal vaccine at baseline. Secondly, it aims to evaluate the impact of a video-led educational intervention on pneumococcal vaccine literacy, willingness to be vaccinated, and the actual uptake of the vaccine. To this end, participants will be recruited through various online channels. Only individuals who have not received the pneumococcal vaccine will be considered eligible for inclusion. For the second objective, participants will be randomly assigned to either the intervention group (short video on pneumococcal vaccination) or the control group (reminder to receive a pneumococcal vaccine). Consenting participants will be required to complete two surveys: one at baseline and another approximately six months post-intervention. These surveys will provide valuable data for analyzing the effectiveness of the educational intervention in improving participants' knowledge, willingness to be vaccinated, and the actual uptake of the pneumococcal vaccine. Findings from this research will contribute to the understanding of factors influencing pneumococcal vaccine decision-making among older adults, ultimately informing strategies to enhance vaccine uptake and public health outcomes in this population.

Interventions

OTHERWeb-based educational video on pneumococcal vaccination

Participants will receive a link to view a short video on pneumococcal vaccination.

OTHERReminder email to be vaccinated

Participants will receive a reminder email to be vaccinated.

Sponsors

University of Ottawa
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Investigator)

Intervention model description

Participants will be randomized 1:1 to receive either a web-based educational video about pneumococcal vaccination and a reminder email to be vaccinated or a reminder email alone.

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. adults aged ≥ 65 residing in any Canadian province, 2. community dwelling (i.e., living outside of nursing homes), 3. reporting not having received a pneumococcal vaccine, and 4. being able to understand English and/or French.

Design outcomes

Primary

MeasureTime frameDescription
Pneumococcal vaccine uptake measured using a web-based follow-up survey four to six months post-randomization4-6 monthsParticipants will be asked at follow-up whether they received a pneumococcal vaccine since the last survey (yes/no/do not know).

Secondary

MeasureTime frameDescription
Change in pneumococcal vaccination willingness, measured using web-based surveys (one at baseline and one four to six months post-randomization)4-6 monthsParticipants will be asked at baseline and follow-up whether they would be willing to receive a pneumococcal vaccine (yes/no/do not know).
Change in pneumococcal vaccine knowledge measured using web-based surveys (one at baseline and one four to six months post-randomization)4-6 monthsParticipants will be asked about their vaccine knowledge at baseline and follow-up (yes/no/do not know).
Change in pneumococcal vaccine attitudes measured using web-based surveys (one at baseline and one four to six months post-randomization)4-6 monthsParticipants will be asked about their vaccine attitudes using Likert-type questions at baseline and follow-up. The response options are on a 5-point Likert scale that ranges from a value of 1 for strongly disagree to a value of 5 for strongly agree. Higher scores indicate stronger agreement with the statement and with the outcome.

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026